Crossmark

Comment on: “Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study”

Crossref DOI link: https://doi.org/10.1007/s11523-020-00725-x

Published Online: 2020-05-27

Published Print: 2020-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Şener, Yusuf Ziya https://orcid.org/0000-0001-5151-5133
License Information

Text and Data Mining valid from 2020-05-27

Version of Record valid from 2020-05-27
More Information

Article History

First Online: 27 May 2020

Compliance with Ethical Standards

:

: No external funding was used in the preparation of this manuscript.

: Yusuf Ziya Şenern declares that he has no conflict of interest that might be relevant to the contents of this manuscript.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below